Apellis Pharmaceuticals Inc

APLS

Equity

ISIN null / Valor 30132056

NASDAQ (2026-05-01)

USD 40.96+0.02%

Apellis Pharmaceuticals Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Apellis Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for autoimmune and inflammatory diseases through the inhibition of the complement system.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

104%1Y

-50.6%3Y

-19.2%5Y

Performance

108%1Y

87.2%3Y

80.6%5Y

Volatility

5236 M

Market cap (USD)

1,714,607

Daily traded volume (Shares)

32.49 / 31.89

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Petros Gakidis

Switzerland, 20 Mar 2022

EQUITIES OF THE SAME SECTOR

Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc Valor: 24511852

Annual Return

-50%0%+50%

Risk level

110

-0.36%USD 21.88

Schrodinger Inc

Schrodinger Inc Valor: 51947209

Annual Return

-50%0%+50%

Risk level

110

3.60%USD 12.39

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

0.35%USD 2.84

Outset Medical Inc

Outset Medical Inc Valor: 56717137

Annual Return

-50%0%+50%

Risk level

110

2.11%USD 4.36

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

-3.59%USD 68.56

Protagonist Therapeutics Inc

Protagonist Therapeutics Inc Valor: 33278818

Annual Return

-50%0%+50%

Risk level

110

-0.61%USD 98.37

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

0.94%USD 2.15

Summit Therapeutics Inc

Summit Therapeutics Inc Valor: 56903013

Annual Return

-50%0%+50%

Risk level

110

-24.91%USD 16.11

Glaukos Corp

Glaukos Corp Valor: 28262610

Annual Return

-50%0%+50%

Risk level

110

-2.40%USD 140.22

Quanterix Corporation

Quanterix Corporation Valor: 39127916

Annual Return

-50%0%+50%

Risk level

110

8.63%USD 3.40

Logos provided by Clearbit

Apellis Pharmaceuticals Inc

APLS

ISIN null / Valor 30132056

Apellis Pharmaceuticals Inc UMushroom community rating:

Petros Gakidis

Apellis Pharmaceuticals Inc
UMushroom community rating: